This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Zealand Pharma A/s. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Søθborg, DK (2022)
- Søborg, DK (2023)
Company Filing History:
Years Active: 2022-2023
Title: Rasmus Bugge Jensen: Innovator in Potassium Channel Blockers
Introduction
Rasmus Bugge Jensen is a notable inventor based in Søborg, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of potassium channel blockers. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Jensen's latest patents focus on Kv1.3 blockers. The present invention provides novel blockers of the potassium channel Kv1.3, polynucleotides encoding them, and methods of making and using them. This innovation is crucial for advancing treatments related to various health conditions.
Career Highlights
Rasmus Bugge Jensen is currently employed at Zealand Pharma A/S, where he continues to push the boundaries of pharmaceutical research. His expertise in potassium channels has positioned him as a key player in the development of new therapeutic solutions.
Collaborations
Some of his notable coworkers include Henrik Fischer Munch and Jens Kvist Madsen. Their collaborative efforts contribute to the innovative environment at Zealand Pharma A/S.
Conclusion
Rasmus Bugge Jensen's work in potassium channel blockers exemplifies the importance of innovation in the pharmaceutical industry. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile